Clinical Trials Browser

Neurofibromatosis 1 × N-monoacetylcystine × Clear all

NCT04481048 2026-06-05

DoDNAC

Phase 2 Completed

25 enrolled 12 charts

Attention Deficit Disorder with Hyperactivity, Neurofibromatosis 1